Le Lézard
Classified in: Health
Subjects: AWD, ASI, DEI

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year


PALO ALTO, Calif., April 12, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score improved by 7.3 percentage points from 2019 to 2020.

In the annual survey results, Varian ranked first in the following 10 categories: Net Promoter Score; Market Share; Satisfaction; Satisfaction in Grade A Hospitals; Product Quality; Services Quality; Services Attitude; Efficiency; Training; and Parts Delivery Time. These survey results demonstrate Varian's ongoing commitment to its customers through quality products and superior and efficient services.

The 11th annual survey, organized by the China Medical Equipment magazine, collected responses from more than 2,000 hospitals across 32 provinces in the country. It is one of the most influential medical industry performance evaluations conducted in China.

The goal of the survey is to understand and evaluate customer satisfaction with the after-sales service provided by medical technology manufacturers, and to provide those companies with information that can help them standardize and improve the quality of their after-sales service programs.

"Meeting and exceeding our customers' needs is our goal each and every day," said Dr. Zhang Xiao, president of Varian Greater China region. "We are grateful for our customers' recognition, reflected by the results of this survey. It encourages us to pursue excellence and empower our work to deliver technology and innovation in the fight against cancer."

About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact
Aimee Corso
Health + Commerce
+1 (310) 780-2661
aimee@healthandcommerce.com

Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com

SOURCE Varian


These press releases may also interest you

at 07:00
ProMIS Neurosciences, Inc. ("ProMIS or the Company"), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced...

at 06:50
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today...

at 06:45
The "Point-of-Care Data Management Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. Cancer Markers Segment to Register Higher...

at 06:35
HEXO Corp ("HEXO" or the "Company") today announced Purchase and Sale Agreements in relation to its first US production facility, through a wholly owned US subsidiary. The ~50,000 sq. ft. facility, located in Northern Colorado, will provide US CPGs...

at 06:30
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Sidney Kimmel Cancer Center ? Jefferson Health (SKCC) has joined Caris'...

at 06:30
The "Artificial Intelligence in Healthcare Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography" report has been added to ResearchAndMarkets.com's offering. Robot Assisted Surgery Segment...



News published on 12 april 2021 at 16:15 and distributed by: